Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...

Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental ...

A team led by Rensselaer Polytechnic Institute (RPI) professors Georges Belfort, Ph.D. (PI), and Pankaj Karande, Ph.D. (co-PI ...

MIT and Broad Institute researchers have developed an mRNA approach that temporarily programs liver cells to produce ...

As support from the U.S. government has evaporated, Moderna is leaning on an old ally to carry plans for its prospective mRNA ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

A newly revealed molecular tug-of-war may have implications for better understanding how a multitude of diseases and ...

Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure ...

A newly revealed molecular tug-of-war may have implications for better understanding how a multitude of diseases and ...

As people age, their immune system function declines. T cell populations become smaller and can't react to pathogens as ...

RNA vaccines, such as those used against COVID-19, are effective at generating antibody responses. These antibodies are ...

New data highlight liver-encoded delivery of immune modulators as a strategy to mitigate age-related immune dysfunction.